title: Technology assessment of the Dutch Lung Transplantation Program.
abstract: The costs, effects, and cost-effectiveness of the Dutch Lung Transplantation program were assessed. The results show that lung transplantation is a very costly intervention that improves survival and quality of life. Costs per life-year and per QALY gained were, respectively, US $90,000 and US $71,000.
authors.affiliation: University Hospital Groningen.
authors.forename: P J
authors.initials: PJ
authors.lastname: van Enckevort
authors.forename: E M
authors.initials: EM
authors.lastname: TenVergert
authors.forename: G J
authors.initials: GJ
authors.lastname: Bonsel
authors.forename: A
authors.initials: A
authors.lastname: Geertsma
authors.forename: W
authors.initials: W
authors.lastname: van der Bij
authors.forename: W J
authors.initials: WJ
authors.lastname: de Boer
authors.forename: M A
authors.initials: MA
authors.lastname: Koopmanschap
authors.forename: M J
authors.initials: MJ
authors.lastname: Al
authors.forename: F F
authors.initials: FF
authors.lastname: Rutten
mesh_terms: D000465:Algorithms; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D008137:Longitudinal Studies; D016040:Lung Transplantation / Q000191:economics* / Q000401:mortality; D009426:Netherlands / Q000453:epidemiology; D018579:Patient Selection; D019057:Quality-Adjusted Life Years; D015996:Survival Rate; D013673:Technology Assessment, Biomedical; D014850:Waiting Lists